4Heep M,Kist M,Strobels S,et al.Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy.Eur J Clin Microbiot Infect Dis,2000,19:538-541.
5Cheon JM,Kim N,Lee DH,et al. Trial of monxifloxacin-containing triple therapy after initi-al and second-line treatment failtures for helicobacter pylori infection. Korean J Gastroent-erol,2005,45 : 111-117.
6Lopes AI, Oleastro M, Palha A, et al. Anfibioticresistant Helicobacter pylori strains in Portugue-se children. Pediatr Infect Dis J,2005,24: 404-409.
7Heep M,Kist M, Strobel S,et al. Secondary resistance among 554 isolates of Helicobacter pylo-ri after failture of therapy. Eur J Clin Microbiol Infect Dis,2000,19:538-541.
8DiCaro S, Assunta Zocco M, Cremonini F, et al. Levofloxacin based regimens for the erad-ication of Helicobacter pylori. Eur J Gastroenterol Hepatol,2002,14 : 1309-1312.
9Perri F, Festa V, Merla A,et al. Randomized study of different'second- line'the rapies for H-elicobacter pylori infection after failure of the standard' Maastricht triple therapy. Alime-nt Pharmacol Ther,2003, 18:815-820.
10Cammarota G, Cianci R, Cannizzaro O ,et al. High-doseversus low-doseclari thromycinin 1-w-eek triple therapy, including rabeprazole and levofloxacin, for Helicobacter pylori eradication. J Clin Gastroenterol, 2004,38:110-114.
